These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 733857)

  • 21. Physiology of the vas deferens.
    Steers WD
    World J Urol; 1994; 12(5):281-5. PubMed ID: 7532517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quantitative structure-activity relationship study of the inhibitory action of a series of enkephalin-like peptides in the guinea pig ileum and mouse vas deferens bioassays.
    Fauchère JL
    J Med Chem; 1982 Dec; 25(12):1428-31. PubMed ID: 7154003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin action on insulin secretion induced by chicken and porcine vasoactive intestinal peptide in the perfused rat pancreas.
    Arilla E; Prieto JC; López-Martínez JM; Goberna R
    Horm Metab Res; 1981 Jun; 13(6):314-7. PubMed ID: 6114916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of cross-tolerance between morphine and Leu-enkephalin in the mouse vas deferens.
    Illes P; Zieglgänsberger W; Herz A
    Brain Res; 1980 Sep; 197(1):260-3. PubMed ID: 6249458
    [No Abstract]   [Full Text] [Related]  

  • 26. Postjunctional inhibition of contractor responses in the mouse vas deferens by rat and human calcitonin gene-related peptides (CGRP).
    Al-Kazwini SJ; Craig RK; Marshall I
    Br J Pharmacol; 1986 May; 88(1):173-80. PubMed ID: 3486688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nine different gastrointestinal polypeptides on vascular smooth muscle in vitro.
    Hellstrand P; Järhult J
    Acta Physiol Scand; 1980 Sep; 110(1):89-94. PubMed ID: 6162366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different effects of current strength on inhibitory responses of the mouse vas deferens to methionine- and leucine-enkephalin.
    Hart SL; Kitchen I; Waddell PR
    Br J Pharmacol; 1979 Jul; 66(3):361-3. PubMed ID: 526704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide and cholinergic neurotransmission in the ciliary muscle.
    Suzuki R; Kobayashi S
    Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):250-3. PubMed ID: 6826329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro.
    Epelbaum J; Tapia-Arancibia L; Besson J; Rotsztejn WH; Kordon C
    Eur J Pharmacol; 1979 Oct; 58(4):493-5. PubMed ID: 510382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect.
    Larsen JJ; Ottesen B; Fahrenkrug J; Fahrenkrug L
    Invest Urol; 1981 Nov; 19(3):211-3. PubMed ID: 7298295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efffect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
    Ryan JP; Ryave S
    Am J Physiol; 1978 Jan; 234(1):E44-6. PubMed ID: 623247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parathyroid hormone (PTH) and PTH-related peptide induce relaxation of smooth muscle cells from guinea pig ileum: interaction with vasoactive intestinal peptide receptors.
    Botella A; Rekik M; Delvaux M; Davicco MJ; Barlet JP; Frexinos J; Bueno L
    Endocrinology; 1994 Nov; 135(5):2160-7. PubMed ID: 7525262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opiate agonists inhibit noradrenaline release via opiate B-receptors and N-cyclopropylmethylnorazidomorphine (CAM) blocks electrically evoked contractions via histamine in the mouse vas deferens.
    Knoll J; Kerecsen L; Somogyi GT; Kovács A
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):52-65. PubMed ID: 6266359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of in vitro prolactin release by vasoactive intestinal peptide.
    Enjalbert A; Arancibia S; Ruberg M; Priam M; Bluet-Pajot MT; Rotsztejn WH; Kordon C
    Neuroendocrinology; 1980 Sep; 31(3):200-4. PubMed ID: 7413020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of vasoactive intestinal polypeptide on myometrial smooth muscle of rabbit and guinea-pig.
    Bolton TB; Lang RJ; Ottesen B
    J Physiol; 1981 Sep; 318():41-55. PubMed ID: 7320897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
    Ottesen B
    Acta Physiol Scand; 1981 Oct; 113(2):193-9. PubMed ID: 6947684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets.
    Bailey CJ; Wilkes LC; Conlon JM; Armstrong PH; Buchanan KD
    J Endocrinol; 1990 Jun; 125(3):375-9. PubMed ID: 1973701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid peptides derived from pre-proenkephalin B sequence: biological evaluation in guinea pig ileum and mouse vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM
    Proc West Pharmacol Soc; 1983; 26():85-8. PubMed ID: 6688470
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors.
    Lew MJ; Murphy R; Angus JA
    Br J Pharmacol; 1996 Apr; 117(8):1768-72. PubMed ID: 8732289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.